- Current report filing (8-K)
December 04 2008 - 8:45AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
December 4, 2008
Date of
Report (date of earliest event reported)
BIOFORM MEDICAL, INC.
(Exact name of Registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
001-33791
|
|
39-1979642
|
(State of incorporation)
|
|
(Commission
File Number)
|
|
(I.R.S. Employer
Identification Number)
|
1875 South Grant Street, Suite 200
San Mateo, California 94402
(Address of principal executive offices)
(650) 286-4000
(Registrants telephone number, including area code)
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
ITEM 5.02.
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
On December 3, 2008, Derek Bertocci, Chief Financial Officer of BioForm Medical, Inc. (Company), tendered his resignation as Chief
Financial Officer and Secretary effective December 31, 2008 to pursue other opportunities outside of the Company. Mr. Bertoccis resignation did not result from any disagreement with, or inaccuracy or omission in, the Companys
accounting systems or financial reporting. All functional areas reporting to Mr. Bertocci will report to Steven L. Basta, Chief Executive Officer of BioForm Medical, until a replacement is appointed. Mr Bertoccis resignation does not
trigger any severance payments.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
BioForm Medical, Inc.
|
|
|
|
|
Date: December 4, 2008
|
|
|
|
By:
|
|
/s/ Steven L. Basta
|
|
|
|
|
|
|
Steven L. Basta
|
|
|
|
|
|
|
Chief Executive Officer
|
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bioform Medical (MM) (NASDAQ:BFRM)
Historical Stock Chart
From Jul 2023 to Jul 2024